Posted on Leave a comment

Multiple Sclerosis Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Novartis AG, Sanofi, F. Hoffmann-La Roche, Celgene Crp., Johnson & Johnson

In 2023, the Multiple Sclerosis Market size was USD 20.559 billion in the United States and the report offers an in-depth understanding of the Multiple Sclerosis, historical and forecasted epidemiology as well as the Multiple Sclerosis market trends in the 7MM. DelveInsight’s “Multiple Sclerosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding […]

Posted on Leave a comment

Diabetic Foot Ulcers Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Medline, B. Braun, Organogenesis, 3M, Smith & Nephew

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Diabetic Foot Ulcers pipeline constitutes 30+ key companies continuously working towards developing 34+ Diabetic Foot Ulcers treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Diabetic Foot Ulcers Pipeline report embraces in-depth commercial and clinical assessment […]

Posted on Leave a comment

MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation

Biotech Stock In Focus Biotech Stocks In Focus MAIA Biotechnology (NYSE: MAIA), Eli Lilly and Company (LLY), Novo Nordisk A/S (NVO), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), AbbVie Inc. (ABBV) MAIA Biotechnology Inc. (NYSE: MAIA) has been making waves in the biotech industry with several recent announcements that have garnered attention from […]

Posted on Leave a comment

UV Absorbers Market Size, Share, Trends, Growth And Forecast To 2032

UV Absorbers Market By Material (Benzophenone, Benzotriazole, Triazine, Others), By Application (Paints & Coatings, Adhesives & Sealants, Plastics, Personal Care, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032 The market for UV absorbers is anticipated to expand at a CAGR of 4.7% during the forecast period of 2024 to 2032. This growth […]

Posted on Leave a comment

PD-1 NSCLC Pipeline Assessment, 2024 Updates | In-depth Insights into the Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, and Treatment Outlook | Genor Biopharma, Shandong Boan

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, PD-1 Non-Small Cell Lung Cancer pipeline constitutes 30+ key companies continuously working towards developing 30+ PD-1 Non-Small Cell Lung Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The PD-1 Non-Small Cell Lung Cancer Pipeline report […]

Posted on Leave a comment

Acromegaly Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Pfizer Inc, Novartis AG, Validus Pharma, Ipsen, Chiasma, Inc, Crinetics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Acromegaly pipeline constitutes 12+ key companies continuously working towards developing 13+ Acromegaly treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Acromegaly Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the […]

Posted on Leave a comment

Celecoxib API Market Poised for Expansion: Reaching $87 Million by 2031

Celecoxib API Market Celecoxib API Market is valued at US$ 58.9 Mn 2023, and it is expected to reach US$ 87.0 Mn by 2031, with a CAGR of 5.1% during the forecast period of 2024-2031. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Celecoxib API Market- (By Type […]

Posted on Leave a comment

Huntington’s Disease Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Spark therapeutics, Chong Kun Dang Pharma, Neuvivo, UniQure Bio

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Huntington’s Disease pipeline constitutes 50+ key companies continuously working towards developing 50+ Huntington’s Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Huntington’s Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline […]

Posted on Leave a comment

Low Grade Glioma Market to Register Incremental Growth During the Forecast Period (2024-2034),Asserts DelveInsight | Day One Biopharma, Servier, SpringWorks Therapeutics, AnHeart Therapeutics, Beigene

The Low Grade Glioma Market size was valued approximately USD 1 billion in 2022 and the report offers an in-depth understanding of the Low Grade Glioma, historical and forecasted epidemiology as well as the Low Grade Glioma market trends in the 7MM. DelveInsight’s “Low Grade Glioma Market Insights, Epidemiology, and Market Forecast-2034″ report offers an […]

Posted on Leave a comment

Respiratory Syncytial Virus Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | GlaxoSmithKline, MedImmune, ReViral, Pfizer, Sanofi, BioComo, IMV

The Respiratory Syncytial Virus Market Forecast report offers an in-depth understanding of the Respiratory Syncytial Virus, historical and forecasted epidemiology as well as the Respiratory Syncytial Virus market trends in the 7MM. DelveInsight’s “Respiratory Syncytial Virus Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Respiratory Syncytial Virus, historical and forecasted […]